Expression of a protease-resistant insulin-like growth factor-binding protein-4 inhibits tumour growth in a murine model of breast cancer
Anderson J. Ryan(University of Oxford), Judith H. Harmey(Royal College of Surgeons in Ireland)
Cited by 65
Related Papers
Combining AKT inhibition with chloroquine and gefitinib prevents compensatory autophagy and induces cell death in EGFR mutated NSCLC cells
|Oncotarget|2014|46
Vandetanib inhibits both VEGFR-2 and EGFR signalling at clinically relevant drug levels in preclinical models of human cancer
|International Journal of Oncology|2011|25
An organotypic model for investigating drug-radiation responses in the lung
|Journal of Biological Methods|2024|1